Cargando…

Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients

Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prevalent disorder with increased risk for the development of cardiomyopathy. Using an untargeted discovery-based lipidomic workflow, we uncovered that transfusion-dependent thalassemia (TDT) patients had a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botta, Amy, Forest, Anik, Daneault, Caroline, Pantopoulos, Kostas, Tantiworawit, Adisak, Phrommintikul, Arintaya, Chattipakorn, Siriporn, Chattipakorn, Nipon, Des Rosiers, Christine, Sweeney, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912378/ https://www.ncbi.nlm.nih.gov/pubmed/33530524 http://dx.doi.org/10.3390/metabo11020070

Ejemplares similares

N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial
por: Pattanakuhar, Sintip, et al.
Publicado: (2020)

Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients
por: Pattanakuhar, Sintip, et al.
Publicado: (2018)

Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia
por: Silvilairat, Suchaya, et al.
Publicado: (2016)

Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients
por: Wijarnpreecha, Karn, et al.
Publicado: (2015)

Exercise and cardioprotection: A “HIP” side of HIPK2 in the heart
por: Phrommintikul, Arintaya, et al.
Publicado: (2021)

An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
por: Theerajangkhaphichai, Wasan, et al.
Publicado: (2021)

Author Correction: An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
por: Theerajangkhaphichai, Wasan, et al.
Publicado: (2023)

Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
por: Osataphan, Nichanan, et al.
Publicado: (2020)

Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia
por: Silvilairat, Suchaya, et al.
Publicado: (2021)

The Possible Link Between Serum Lipocalin-2 Level and Mild Cognitive Impairment in Adults With Metabolic Syndrome
por: Pinyopornpanish, Kanokporn, et al.
Publicado: (2021)

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: the different roles of FGF21
por: Phrommintikul, Arintaya, et al.
Publicado: (2018)

The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome
por: Sawangpanyangkura, Teerat, et al.
Publicado: (2022)

Circulating Lipocalin-2 level is positively associated with cognitive impairment in patients with metabolic syndrome
por: Pinyopornpanish, Kanokporn, et al.
Publicado: (2022)

Gut Microbiota Profiles of Treated Metabolic Syndrome Patients and their Relationship with Metabolic Health
por: Wutthi-in, Montree, et al.
Publicado: (2020)

Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial
por: Osataphan, Nichanan, et al.
Publicado: (2023)

Leukocyte telomere length in patients with transfusion-dependent thalassemia
por: Nanthatanti, Nithita, et al.
Publicado: (2020)

Electrophysiological Mechanisms of Ventricular Fibrillation Induction
por: Chattipakorn, Nipon, et al.
Publicado: (2005)

Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury
por: Weerateerangkul, Punate, et al.
Publicado: (2011)

Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats
por: Pongkan, Wanpitak, et al.
Publicado: (2015)

Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
por: Lahnwong, Sarayut, et al.
Publicado: (2018)

Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
por: Sripetchwandee, Jirapas, et al.
Publicado: (2018)

Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches
por: Kusirisin, Prit, et al.
Publicado: (2020)

Staying fit and the obese aging heart condition
por: Thonusin, Chanisa, et al.
Publicado: (2021)

Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches
por: Narongkiatikhun, Phoom, et al.
Publicado: (2021)

Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
por: Attachaipanich, Tanawat, et al.
Publicado: (2023)

Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
por: Maneechote, Chayodom, et al.
Publicado: (2023)

Cognitive impairment is associated with mitochondrial dysfunction in peripheral blood mononuclear cells of elderly population
por: Apaijai, Nattayaporn, et al.
Publicado: (2020)

Cardiorenal syndrome in thalassemia patients
por: Makmettakul, Sorasak, et al.
Publicado: (2020)

Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity
por: Sripetchwandee, Jirapas, et al.
Publicado: (2014)

Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
por: Chattipakorn, Siriporn C., et al.
Publicado: (2014)

Effects of Kaempferia parviflora Wall. Ex. Baker on electrophysiology of the swine hearts
por: Weerateerangkul, Punate, et al.
Publicado: (2013)

Pharmacological Properties of Protocatechuic Acid and Its Potential Roles as Complementary Medicine
por: Semaming, Yoswaris, et al.
Publicado: (2015)

Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
por: Maneechote, Chayodom, et al.
Publicado: (2017)

Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury
por: Intachai, Kannaporn, et al.
Publicado: (2018)

Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient
por: Nantsupawat, Teerapat, et al.
Publicado: (2020)

Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma
por: Nimitrungtawee, Natthaphong, et al.
Publicado: (2021)

Human Blood Bacteriome: Eubiotic and Dysbiotic States in Health and Diseases
por: Suparan, Kanokphong, et al.
Publicado: (2022)

Effects of Particulate Matter on Inflammation and Thrombosis: Past Evidence for Future Prevention
por: Hantrakool, Sasinee, et al.
Publicado: (2022)

Hydrogen therapy as a potential therapeutic intervention in heart disease: from the past evidence to future application
por: Saengsin, Kwannapas, et al.
Publicado: (2023)

Circulating mitochondrial dysfunction as an early biomarker for contrast media‐induced acute kidney injury in chronic kidney disease patients
por: Kusirisin, Prit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6dni09578iesndpjh6dumut3o1